We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Deltex Medical Group plc (DEMG) Ordinary 1p

Sell:0.07p Buy:0.09p 0 Change: No change
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.07p
Buy:0.09p
Change: No change
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.07p
Buy:0.09p
Change: No change
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Deltex Medical Group Plc is a United Kingdom-based medical device company. The Company develops, manufactures and distributes a hemodynamic monitoring technology. The Company's TrueVue platform offers three monitoring technologies, such as Oesophageal Doppler Monitoring (ODM+), Pulse Pressure Waveform Analysis (PPWA) and High Definition Impedance CardioGraphy (HD-ICG). Its ODM+ is a fluid management and cardiac output monitoring technology to directly measure both flow and pressure in adults and pediatrics. HD-ICG provides continuous and sensitive measurements of cardiac output and other hemodynamic parameters. The system is stabilized using HD-Z signal filter technology. HD-ICG disposable electrodes are placed on the neck and chest. PPWA uses the researched pulse pressure wave algorithm, which is available to derive hemodynamic parameters, calibrated from the Doppler. Its applications include surgery, acute kidney injury, enhanced recovery, paediatric, and COVID-19 critical care.

Contact details

Address:
Terminus Road
CHICHESTER
PO19 8TX
United Kingdom
Telephone:
+44 (01243) 774837
Website:
https://www.deltexmedical.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 23 September 2024 23/09/24
Trading Announcement 04 July 2024 04/07/24
AGM 08 May 2024 08/05/24
Final results 28 March 2024 28/03/24
Annual report 28 March 2024 28/03/24
Trading Announcement 18 January 2024 18/01/24

General stock information

EPIC:
DEMG
ISIN:
GB0059337583
Market cap:
£1.52 million
Shares in issue:
1.90 billion
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Andy Mears
    Chief Executive, Executive Director
  • Natalie Wettler
    Group Finance Director, Chief Operating Officer, Executive Director, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.